APA (7th ed.) Citation

Welzen, B., Mudrikova, T., Arends, J., & Hoepelman, A. (2012). No increased risk of hepatotoxicity in long-term use of nonnucleoside reverse transcriptase inhibitors in HIV-infected patients. HIV Medicine, 13(7), 448. https://doi.org/10.1111/j.1468-1293.2012.00995.x

Chicago Style (17th ed.) Citation

Welzen, BJ, T. Mudrikova, JE Arends, and AIM Hoepelman. "No Increased Risk of Hepatotoxicity in Long-term Use of Nonnucleoside Reverse Transcriptase Inhibitors in HIV-infected Patients." HIV Medicine 13, no. 7 (2012): 448. https://doi.org/10.1111/j.1468-1293.2012.00995.x.

MLA (9th ed.) Citation

Welzen, BJ, et al. "No Increased Risk of Hepatotoxicity in Long-term Use of Nonnucleoside Reverse Transcriptase Inhibitors in HIV-infected Patients." HIV Medicine, vol. 13, no. 7, 2012, p. 448, https://doi.org/10.1111/j.1468-1293.2012.00995.x.